Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

INVega Is Studied In an Observational Design in the Netherlands.

Trial Profile

INVega Is Studied In an Observational Design in the Netherlands.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2014

At a glance

  • Drugs Paliperidone (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms INVISION
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 06 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Planned number of patients changed from 250 to 27 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top